Kroeger Christopher A.
Known title: Chief Executive OfficerCIK: 0001658918
Associated companies
Transaction History
| MPLT | ▲ Buy | Grant | 23,145 | $0 | 8/17/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 16,779 | $636K | 7/17/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 40,899 | $1.5M | 7/16/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 28,091 | $1.0M | 7/16/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 92 | $3K | 7/16/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 18,950 | $682K | 7/15/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 42,738 | $1.6M | 7/15/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 90 | $3K | 7/15/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 118,037 | $3.2M | 5/18/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 198 | $6K | 5/18/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 342 | $9K | 5/11/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 877 | $25K | 5/11/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 6,871 | $206K | 5/11/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 5,890 | $180K | 5/11/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 29,624 | $814K | 5/8/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 1,582 | $45K | 5/8/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 3,205 | $94K | 5/8/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 5,220 | $152K | 5/7/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 14,880 | $424K | 5/7/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 8,098 | $227K | 5/6/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 15,603 | $455K | 5/6/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 9,544 | $268K | 5/5/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 928 | $27K | 5/5/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 9,136 | $251K | 5/4/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 5,427 | $154K | 5/4/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 311 | $9K | 5/4/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 697 | $21K | 5/4/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 2,477 | $67K | 4/16/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 7,575 | $208K | 4/16/2026 | View on chart |
| MPLT | ▼ Sell | Open Market | 9,135 | $246K | 4/15/2026 | View on chart |
| MPLT | ▲ Buy | Grant | 23,145 | $0 | 2/5/2026 | View on chart |
| MPLT | ▼ Sell | Tax Withholding | 204,146 | $3.7M | 1/27/2026 | View on chart |
| MPLT | ▼ Sell | Other | 3,895 | — | 10/28/2025 | View on chart |
| MPLT | ▲ Buy | Grant | 225,693 | $0 | 10/27/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
MapLight Therapeutics Shares Fall 34.8% in Four Weeks
MapLight Therapeutics stock has dropped 34.8% over the past month, leading some market observers to discuss potential for a turnaround. The decline places the stock near its 52-week low of $8.70, while the current RSI of 21.9 suggests the shares are in oversold territory. Analysts maintain an average price target of $26.54, indicating a wide range of expectations for the company's future performance.
MapLight Therapeutics Shares Fall 34.8% in Four Weeks. MapLight Therapeutics stock has dropped 34.8% over the past month, leading some market observers to discuss potential for a turnaround. The decline places the stock near its 52-week low of $8.70, while the current RSI of 21.9 suggests the shares are in oversold territory. Analysts maintain an average price target of $26.54, indicating a wide range of expectations for the company's future performance.